TCG Lifesciences Limited ("TCGLS") announced the nomination of a pre-clinical development candidate ("Candidate") under a R&D collaboration entered into in 2009 with Pfizer Inc. ("Pfizer"). As per the agreement, Pfizer will own the Candidate and other back up candidates while TCGLS will receive a milestone payment for its success in moving these molecules to the candidate stage.
The Candidate is a small molecule new chemical entity that meets all the success criteria set by Pfizer, including potency, pharmacokinetics, animal p ...
tcg lifesciences limited (tcgls) announced the achievement of two distinct milestones in their ongoing drug discovery partnership with endo pharmaceuticals. Tcgls will receive undisclosed success fees against these milestones.
In the first of two fully integrated discovery programs with Endo aimed at identifying novel small molecule drug candidates for an unmet medical need, ...
TCG Lifesciences Limited (TCGLS) has announced that it has entered into a strategic agreement with JSW Lifesciences (JSW), a full services EU based CRO, to strengthen its R&D offerings in the area of Central Nervous System (CNS).
Kolkata, India - This agreement will enable TCGLS and JSW to offer specialized preclinical and early clinical development services in the neuroscience ...
Cancer Trials Australia collaborated with Mumbai based Clininvent Research Private Limited to leverage complimentary capabilities in selected areas of clinical development and offer services spanning phases I to IV, to clients in Australia and India.
Mumbai, India: Cancer Trials Australia (CTA) announced that it has entered into a collaboration agreement with Mumbai based Clininvent Research Privat ...